Molecular formula: | C10H12ClN5O3 |
Average mass: | 285.688 |
Monoisotopic mass: | 285.062867 |
ChemSpider ID: | 19105 |
3 of 3 defined stereocentres
Wikipedia
Spectra
(2R,3S,5R)-5-(6-Amino-2-chlor-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxyméthyl)tétrahydrofuran-3-ol
2-Chlor-2′-desoxyadenosin
[German]
[ACD/IUPAC Name]2-Chloro-2'-deoxyadenosine
2-Chloro-2′-deoxy-adenosine
2-Chloro-2′-deoxy-b-adenosine
2-Chloro-2′-deoxy-β-adenosine
2-Chloro-2′-deoxyadenosine
[ACD/IUPAC Name]2-Chloro-2′-désoxyadénosine
[French]
[ACD/IUPAC Name]2-Chloro-6-amino-9-(2-deoxy-b-D-erythro-pentofuranosyl)purine
2-chloro-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine
2-Chlorodeoxyadenosine
4291-63-8
[RN]adenosine, 2-chloro-2′-deoxy-
[ACD/Index Name]CDA
Cladaribine
cladribinum
[Latin]
[INN]Litak
[Trade name]Mavenclad
[Trade name]MFCD00153939
[MDL number]Movectro
[Trade name](2R,3S,5R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-tetrahydrofuranol
(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-methylol-tetrahydrofuran-3-ol
(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
2-CDA
2-CHLORO-2'
2-Chloro-2-deoxyadenosine
2-Chloro-2ʹ
2-CHLORO-2′-DEOXYADENOSINE[8-3H]
2-Chloro-6-amino-9-(2-deoxy-β-D-erythropentofuranosyl)purine
2-chloro-deoxyadenosine
24757-90-2
[RN]2CdA
2CdA, Cladribine
2ClAdo
4826-71-5
[RN]9-(2-deoxy-β-D-ribofuranosyl)-2-chloro-adenine
98%
Adenosine, 2-chloro-2′-deoxy
B2L11_HUMAN
Bcl-2-like protein 11
Chlorodeoxyadenosine
cid_20279
Cladiribine
cladribina
cladribinum
CldAdo
E′Cladribine′
Leustat
Mylinax
Nuclear receptor ROR-α
RORA_HUMAN
Steroidogenic factor 1
STF1_HUMAN
кладрибин
[Russian]كلادريبين
[Arabic]克拉立滨
[Chinese]